Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Review of RRx-001: A Late-Stage Multi-Indication Inhibitor of NLRP3 Activation and Chronic Inflammation
Nanthini Jayabalan, Bryan Oronsky, Pedro Cabrales, et al.
Drugs (2023) Vol. 83, Iss. 5, pp. 389-402
Open Access | Times Cited: 25

Showing 25 citing articles:

NLRP inflammasomes in health and disease
Zhihao Xu, Arnaud John Kombe Kombe, Shasha Deng, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 21
Inflammasome: structure, biological functions, and therapeutic targets
Dai Ya-li, Jing Zhou, Chunmeng Shi
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 29
The Cancer Antioxidant Regulation System in Therapeutic Resistance
Xuanhao Gu, Chunyang Mu, Rujia Zheng, et al.
Antioxidants (2024) Vol. 13, Iss. 7, pp. 778-778
Open Access | Times Cited: 9
The NLRP3 inflammasome: role in the pathobiology of chronic pain
Chen Chen, Maree T. Smith
Inflammopharmacology (2023) Vol. 31, Iss. 4, pp. 1589-1603
Open Access | Times Cited: 21
Pyroptosis and inflammasomes in cancer and inflammation
Jie‐Lin Wang, Shengni Hua, Hai‐Juan Bao, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 17
Medicinal chemistry strategies targeting NLRP3 inflammasome pathway: A recent update from 2019 to mid-2023
Meibo Duan, Lei Sun, Xinzi He, et al.
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115750-115750
Closed Access | Times Cited: 16
RRx-001: a chimeric triple action NLRP3 inhibitor, Nrf2 inducer, and nitric oxide superagonist
Bryan Oronsky, Lori H. Takahashi, Richard D. Gordon, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 15
Ion transporter cascade, reactive astrogliosis and cerebrovascular diseases
Md Shamim Rahman, Rabia Islam, Mohammad Iqbal H. Bhuiyan
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Harnessing ferroptosis for precision oncology: challenges and prospects
Roberto Fernández-Acosta, Iuliana Vintea, Ine Koeken, et al.
BMC Biology (2025) Vol. 23, Iss. 1
Open Access
NLRP3 Inflammasome-mediated pyroptosis in acute lung injury: Roles of main lung cell types and therapeutic perspectives
Jing Wang, Lulu Li, Zhen‐Ao Zhao, et al.
International Immunopharmacology (2025) Vol. 154, pp. 114560-114560
Closed Access
Decoding NLRP3 Inflammasome Activation in Alzheimer’s Disease: A Focus on Receptor Dynamics
Ranika Maurya, Abha Sharma, Saba Naqvi
Molecular Neurobiology (2025)
Closed Access
Targeting NLRP3 Inflammasome: Structure, Function, and Inhibitors
Shengying Lou, Miaolian Wu, Sunliang Cui
Current Medicinal Chemistry (2024) Vol. 31, Iss. 15, pp. 2021-2051
Closed Access | Times Cited: 3
A multicenter, phase 1, dose escalation clinical trial (G-FORCE-1) of XRT, RRx-001 and temozolomide followed by temozolomide +/- RRx-001 in newly diagnosed glioblastoma
Howard A. Fine, Tony Reid, Scott Caroen, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
Targeting the NLRP3 inflammasome signalling for the management of atrial fibrillation
Alisha Niskala, Jordi Heijman, Dobromir Dobrev, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 2
Dissociative Electron Attachment Dynamics of a Promising Cancer Drug Indicates Its Radiosensitizing Potential
Farhad Izadi, Thomas F. M. Luxford, Barbora Sedmidubská, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 41
Closed Access | Times Cited: 2
TGF-β: the apex predator of immune checkpoints
Bryan Oronsky, Pedro Cabrales, Hossein Heidary, et al.
Future Oncology (2023) Vol. 19, Iss. 30, pp. 2013-2015
Open Access | Times Cited: 4
Navigating from cellular phenotypic screen to clinical candidate: selective targeting of the NLRP3 inflammasome
Rosalie Matico, Karolien Grauwen, Dhruv Chauhan, et al.
EMBO Molecular Medicine (2024) Vol. 17, Iss. 1, pp. 54-84
Closed Access | Times Cited: 1
Protein-protein interactions and related inhibitors involved in the NLRP3 inflammasome pathway
Zhenyu Ma, Cheng Jiang, Lili Xu
Cytokine & Growth Factor Reviews (2023) Vol. 74, pp. 14-28
Closed Access | Times Cited: 3
Lost at SCLC: a review of potential platinum sensitizers
Bryan Oronsky, Nacer Abrouk, Li Mao, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 4, pp. 1573-1578
Open Access
RRx-001 Affects Multiple Toxicities in Patients Receiving Concomitant Chemoradiation for Head and Neck Cancers: Observations of the PREVLAR Phase II Trial
Marcelo Bonomi, D.M. Blakaj, David J. Sher, et al.
JCO oncology advances. (2024), Iss. 1
Closed Access
The Role of Glucose-6-Phosphate Dehydrogenase in Skin Cancer Metabolism: A Paradigm Shift in Treatment Approaches
Anusha Abdullah, Jörg Kumbrink, Paris Liokatis, et al.
Cancers (2024) Vol. 17, Iss. 1, pp. 48-48
Open Access
Dissoziative Elektronenanlagerungsdynamik eines vielversprechenden Krebsmedikaments zeigt sein Potential als Radiosensitizer
Farhad Izadi, Thomas F. M. Luxford, Barbora Sedmidubská, et al.
Angewandte Chemie (2024) Vol. 136, Iss. 41
Open Access
Preclinical testing of RRx-001 in mouse models of experimental endometriosis reveals promising therapeutic impacts
Iona McIntyre, V. B. Vasilyev, C. Perrone, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
The role of NLRP3 and NLRP12 inflammasomes in glioblastoma
Sushmita Rajkhowa, Sushmita Jha
Genes and Immunity (2024)
Closed Access
Data Management 101 for drug developers: A peek behind the curtain
Bryan Oronsky, Erica Burbano, Meaghan Stirn, et al.
Clinical and Translational Science (2023) Vol. 16, Iss. 9, pp. 1497-1509
Open Access | Times Cited: 1
Page 1

Scroll to top